In a retrospective analysis of 133 patients with r/r lymphoma receiving CAR T, early cytopenia was associated with peak IL-6, CRP, and ferritin levels as well as incidence and severity of CRS, illustrating that management of baseline inflammation and inflammatory toxicities may decrease incidence and severity of post-infusion cytopenias [16]. This evidence concerns the gene IL6 and congenital rubella syndrome.